Based on the unique understanding of China pharmaceutical market and the introduction ability of Multinational Companies’ technologies and products, Maxmind integrates international and domestic resources by building a bridge linking China market and international innovations. Maxmind has been adopting a higher perspective of analyzing technology and market, licensing in brand, patents or proprietary technologies from international pharmaceutical enterprises on the purpose of quality and management system improvement, has forged a strong portfolio of products with practical and innovative characteristics.
